July 03, 2023
- A recent review reveals that gut microbiota and its metabolites are implicated in pesticide-induced symptoms of autism. However, the role of specific microbiota strains and mechanisms in pesticide-related autism still needs to be studied. The authors suggest upcoming epidemiological studies on this subject should be based on actual exposure patterns and dosage.
- Traditional methods of tracking sleep via polysomnography can be uncomfortable and anxiety-provoking for those on the spectrum who may already have sensory, communication, or behavioral difficulties. A new article showcases how multiple labs are working on developing minimally invasive sleep-tracking devices, such as the Dreem headband, smartwatches like the EmbracePlus, and the Emerald sleep tracker. These devices can track sleep stages and specific aspects of a sleeper’s physiology and brain activity, offering a more ecologically valid way to observe sleep oscillations of people sleeping in their own beds. Researchers hope these devices will help increase the number of patients with autism in sleep studies and potentially lead to new interventions to improve sleep and ease other spectrum-linked traits.
- Arbaclofen, a drug that dampens neuronal activity, has been found to alleviate atypical behaviors in multiple mouse models of an autism-linked genetic condition (16p11.2 deletion), according to a new study. The drug, which has been considered as a fragile X syndrome treatment, was previously found to improve social behaviors in people with the condition. However, its effects on people with autism have been mixed. This new study aimed to combat publishing bias by bringing together a consortium of labs to test arbaclofen in a standardized fashion in three different 16p11.2 mouse models. The results showed the drug improved cognitive and behavioral issues in the mice. The next stop for the drug is a clinical trial for people with 16p11.2 deletion, which is now recruiting participants. This trial expects to end in March 2025.
- Save the date for Ascendigo’s Blue Aspen Mardi Gras-themed party at the St. Regis Aspen Resort on February 17, 2024. Ascendigo Blue Aspen is the signature fundraising event of Ascendigo Autism Services. This amazing evening anchors an exciting weekend of festivities. This fundraiser is designed to bring awareness and financial support to Ascendigo and its mission: to elevate the spectrum by empowering people, inspiring lives, and shattering expectations.
- Don’t miss the Autism Research Institute’s rescheduled Social Media Use Webinar for adults and teens with autism. The free event will occur on Wednesday, July 26, 2023, at 1 p.m. EDT. Learn about the latest research on the impact of social media use on teens and adults on the spectrum from Dr. Wisniewski, an Associate Professor in Human-Computer Interaction.
